SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : wla(warner lambert)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Carragher who wrote (511)1/28/1999 9:27:00 AM
From: Anthony Wong   of 942
 
WLA options activity yesterday:

Elsewhere on the AMEX, traders noted heavy selling of April 65 puts on Warner Lambert Co. (NYSE:WLA - news) after the drug company said it would buy biotech concern Agouron Pharmaceuticals Inc. (Nasdaq:AGPH - news), known for its AIDS treatment Viracept.

''Put selling is usually a bullish transaction,'' Schwartz said. ''It's an attractive way to own the stock below the market.''

Warner Lambert stock climbed 3-5/8 to 72-1/8.

U.S. OPTIONS Wednesday January 27, 10:00 pm Eastern Time
biz.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News